________________________________________________________________________________________________________________________________

(C) Wolf G Kroner 2016 - Tobias A ThieleThe Laboratory Furniture Market
Assessment and Outlook by Tobias Thiele, Managing Director of Köttermann Group

May 2016. Novel technologies in its environment undermine established business models of laboratory furniture manufacturers. Many still thrive on comfortable margins, unchanged regulations, the separation of buyers and payors (e.g. in the public sector), handed down technical know how. It is not uncommon to find product developers unfamiliar with the work of target users like biologists or chemists.

Tobias Thiele, was Managing Partner of the Köttermann Group. In the exclusive interview he answers tricky questions and offers a strategic view on the furniture industry which is challenged by newcomers like IKEA, as well as by an increasingly sophisticated demand side ranging from Do-it-yourself lab scientists to big pharma customers like Novartis commissioning “personalised” furniture from others.

If you like to read this article, you can purchase it now

Please notice, only private buyers qualify for an individual license. If you order via an organisational address you must choose an organisational sharing license. Whenpurchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 6 pages
- Includes Data Overview on U.S. Laboratory Market 2015; Assessment of Safety and Oversight on Fume Cupboards in Far East by XiangQian Lin, Esco Group (SG) / Singapore Venture Capital and Private Equity Association, and other useful data added by B2Bioworld.

Full Company License enquire here

Back to section

Editor's Note

Since October 2015 Köttermann owns strategic IP from MACH-AIRE Ltd. (UK). IP rights are to fume cupboards and local exhaust ventilation technology some of which were developed in China by Mach Aire Shanghai Clean Air Technology. The IP was transferred to MACH-AIRE Technologies Ltd. which is managed since mid-August 2015 by Kottermann Ltd. (UK), a fully-owned subsidiary by Köttermann & Kochen GmbH, Uetze-Hänigsen (DE). Until the divestiture steel fume board components of Mach-Aire Ltd. were supplied by its subsidiary EMF Manufacturing Ltd.

Mach-Aire’s IP is particularly valuable for Köttermann, because its focus is on the integration of processes such as room pressure control systems combined with exhaust ventilation. Moreover demand for fume cupboards has been emphasizing movable cabinets which require more sophisticated ventilation as well as electronic controls. In addition Mach-Aire’s R&D concentrated on issues of enhanced visual observation resp. transparency of cabinets, which is intimately related to safety aspects of (movable) fume cupboards (see details in the article). During the last years fume cupboard manufacturers in China, Japan, or Korea have been spurring R&D in order to gain a competitive edge in a market dominated by U.S. and European suppliers. Mach-Aire (UK) was among those having recognized early the potential and invested Far East.

Get more background. Read the Article
Free of adverts

Related Editorial Articles

B2Bioworld offers you background information

I want to do, what I want to do
Autophagy researcher Thomas Wollert about living for Science, and not compromising with dealers

Solutions Marketing Never Dreamt of…
Bayer CropScience: Hidden Potentials, Revaluation of IP Assets, and Substantial Changes in R&D

Make or Break Drug Discovery and Biopharma of Merck Life Science
Andrew Bulpin, Global Head of Merck Millipore Process Solutions on strategy and the road ahead. Includes competitive ranking of Merck Life Science Division

Instrument Standards: We need the users, and users have to adopt it
A Global View on Interconnectivity, Quality, Harmonisation of Standards of Laboratory Automation and Biomanufacturing by Oscar-Werner Reif, Member of Board Sartorius Stedim Biotech S.A.

Roche Ethiopia: Build-up of an emerging market

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, past Chief Technology Officer Life Sciences at Tecan on strengths and weaknesses of electrowetting development, weaknesses of competitors like Illumina. Prospects of clinical microfluidics

Riding ahead of demand in the trade fair industry
Jochen Köckler of Deutsche Messe AG about strategic assumptions and business in different parts of the world

Kroner WG (2015): Das Labor der Zukunft verändert die Branche. (The Laboratory of The Future Impacts The Supply Side). Laborwelt, March.

What Future for the Chemicals Industry?
Stefan Marcinowski, past Board Member BASF SE

Handling Suppliers of Mass Spectrometers Delicately
Michael Myers, International Centre for Genetic Engineering and Biotechnology, Trieste (IT) tells how he avoids getting trapped by manufacturers of mass spectrometers and their strategies to fend off competitors with proprietary data formats